During the past decade, Methodist Dallas Medical Center Pharmacy conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Methodist Dallas Medical Center Pharmacy" are "Ascites" (1 trials), "Fluid Loss" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Methodist Dallas Medical Center Pharmacy" in a lesser frequency.

Most popular intervention types in "Methodist Dallas Medical Center Pharmacy" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dermabond" (1 trials) and "sacubitril/valsartan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Methodist Dallas Medical Center Pharmacy" are 1 trials for "All" genders.

Currently, there are NaN active trials in "Methodist Dallas Medical Center Pharmacy". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were undefined completed trials in Methodist Dallas Medical Center Pharmacy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Methodist Dallas Medical Center Pharmacy, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".